NASDAQ: CVRX
Cvrx Inc Stock Ownership - Who owns Cvrx?

Insider buying vs selling

Have Cvrx Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Paul VerrastroCHIEF MKTG STRAT OFFICER2024-11-191,430$13.58
$19.42kSell
Paul VerrastroCHIEF MKTG STRAT OFFICER2024-11-192,500$5.14
$12.85kBuy
Joseph P. SlatteryDirector2024-08-153,000$8.10
$24.30kBuy
Joseph P. SlatteryDirector2024-08-083,000$8.24
$24.72kBuy
Joseph P. SlatteryDirector2024-08-062,500$9.09
$22.73kBuy
Kevin HykesPRES CEO2024-08-0530,000$8.36
$250.77kBuy

1 of 1

CVRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CVRX insiders and whales buy or sell their stock.

CVRX Shareholders

What type of owners hold Cvrx Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Johnson Johnson29.19%7,599,005$56.16MInsider
Johnson Johnson15.76%4,103,430$30.32MInstitution
Johnson Innovatio Johnson13.43%3,495,575$25.83MInsider
Nea Partners 10 L P8.45%2,200,855$16.26MInsider
New Enterprise Associates 10 L P7.78%2,026,083$14.97MInsider
Nea Management Company LLC7.78%2,026,083$14.97MInstitution
Geoffrey B. Pardo7.02%1,829,022$13.52MInsider
Kirk G. Nielsen6.57%1,711,355$12.65MInsider
Glaxosmithkline PLC3.87%1,007,583$7.45MInsider
Mudit K. Jain3.60%936,783$6.92MInsider

1 of 3

CVRX vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CVRX41.61%58.39%Net Buying
MASS44.01%55.99%Net BuyingNet Selling
INGN71.10%28.90%Net SellingNet Selling
LUNG86.01%13.99%Net SellingNet Selling
ELMD26.79%73.21%Net SellingNet Selling

Cvrx Stock Ownership FAQ

Who owns Cvrx?

Cvrx (NASDAQ: CVRX) is owned by 58.21% institutional shareholders, 81.67% Cvrx insiders, and 0.00% retail investors. Johnson Johnson is the largest individual Cvrx shareholder, owning 7.60M shares representing 29.19% of the company. Johnson Johnson's Cvrx shares are currently valued at $55.62M.

If you're new to stock investing, here's how to buy Cvrx stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.